BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35970297)

  • 1. Nucleic acid-based therapy for brain cancer: Challenges and strategies.
    Zhang Z; Conniot J; Amorim J; Jin Y; Prasad R; Yan X; Fan K; Conde J
    J Control Release; 2022 Oct; 350():80-92. PubMed ID: 35970297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleic acid drug vectors for diagnosis and treatment of brain diseases.
    Lu ZG; Shen J; Yang J; Wang JW; Zhao RC; Zhang TL; Guo J; Zhang X
    Signal Transduct Target Ther; 2023 Jan; 8(1):39. PubMed ID: 36650130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNS Delivery of Nucleic Acid Therapeutics: Beyond the Blood-Brain Barrier and Towards Specific Cellular Targeting.
    D'Souza A; Nozohouri S; Bleier BS; Amiji MM
    Pharm Res; 2023 Jan; 40(1):77-105. PubMed ID: 36380168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy.
    Chen C; Yang Z; Tang X
    Med Res Rev; 2018 May; 38(3):829-869. PubMed ID: 29315675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced strategies for nucleic acids and small-molecular drugs in combined anticancer therapy.
    Qiu C; Wu Y; Shi Q; Guo Q; Zhang J; Meng Y; Wang C; Xia F; Wang J; Xu C
    Int J Biol Sci; 2023; 19(3):789-810. PubMed ID: 36778126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spherical Nucleic Acid Nanoparticles: Therapeutic Potential.
    Kapadia CH; Melamed JR; Day ES
    BioDrugs; 2018 Aug; 32(4):297-309. PubMed ID: 29959665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced approaches to overcome biological barriers in respiratory and systemic routes of administration for enhanced nucleic acid delivery to the lung.
    Kwak G; Lee D; Suk JS
    Expert Opin Drug Deliv; 2023; 20(11):1531-1552. PubMed ID: 37946533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in modification and delivery of nucleic acid drugs.
    Wang J; Tan M; Wang Y; Liu X; Lin A
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):417-428. PubMed ID: 37643976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Exogenous Enzymes in Human Therapy: Approved Drugs and Potential Applications.
    Cioni P; Gabellieri E; Campanini B; Bettati S; Raboni S
    Curr Med Chem; 2022; 29(3):411-452. PubMed ID: 34259137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral delivery of nucleic acid therapeutics: Challenges, strategies, and opportunities.
    Jiang X; Wang N; Liu C; Zhuo Y; Liang L; Gan Y; Yu M
    Drug Discov Today; 2023 Apr; 28(4):103507. PubMed ID: 36690175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approval of Cancer Drugs With Uncertain Therapeutic Value: A Comparison of Regulatory Decisions in Europe and the United States.
    Salcher-Konrad M; Naci H; Davis C
    Milbank Q; 2020 Dec; 98(4):1219-1256. PubMed ID: 33021339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Food and Drug Administration vs European Medicines Agency: Review times and clinical evidence on novel drugs at the time of approval.
    Joppi R; Bertele V; Vannini T; Garattini S; Banzi R
    Br J Clin Pharmacol; 2020 Jan; 86(1):170-174. PubMed ID: 31657044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendrimer-based delivery of macromolecules for the treatment of brain tumor.
    Choudhury H; Pandey M; Mohgan R; Jong JSJ; David RN; Ngan WY; Chin TL; Ting S; Kesharwani P; Gorain B
    Biomater Adv; 2022 Oct; 141():213118. PubMed ID: 36182834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Delivery Systems and Strategies to Overcome the Barriers of Brain.
    Garg Y; Kapoor DN; Sharma AK; Bhatia A
    Curr Pharm Des; 2022; 28(8):619-641. PubMed ID: 34951356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleic Acid-Based Therapeutics for Pulmonary Diseases.
    Chen J; Tang Y; Liu Y; Dou Y
    AAPS PharmSciTech; 2018 Nov; 19(8):3670-3680. PubMed ID: 30338490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted nucleic acid delivery into tumors: new avenues for cancer therapy.
    Wagner E; Kircheis R; Walker GF
    Biomed Pharmacother; 2004 Apr; 58(3):152-61. PubMed ID: 15082337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnology-Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID-19 Vaccines.
    Rinoldi C; Zargarian SS; Nakielski P; Li X; Liguori A; Petronella F; Presutti D; Wang Q; Costantini M; De Sio L; Gualandi C; Ding B; Pierini F
    Small Methods; 2021 Sep; 5(9):e2100402. PubMed ID: 34514087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in delivery of drug-nucleic acid combinations for cancer treatment.
    Li J; Wang Y; Zhu Y; Oupický D
    J Control Release; 2013 Dec; 172(2):589-600. PubMed ID: 23624358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.
    Xu L; Anchordoquy T
    J Pharm Sci; 2011 Jan; 100(1):38-52. PubMed ID: 20575003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.